Revolutionizing precision diagnostics

BostonGene offers a comprehensive portfolio of advanced diagnostic tools and technologies to support clinical decision-making, facilitate drug development, and improve patient outcomes.



Through BostonGene, we are utilizing multiparametric discovery and big data analytics to uncover and validate biomarkers of therapeutic response.
We look forward to using BostonGene’s technology to facilitate our work in mechanisms of cancer neoantigen recognition.
Together, we are working to identify novel biomarkers and develop next-generation therapies for a true personalized approach to cancer care.
A tumor ‘‘personality’’ test: the BostonGene Tumor Portrait™ serves as a roadmap to guide treatment decision-making.
Core values

BostonGene’s mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and reduce the overall cost of cancer care.

BostonGene’s tests reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies.